EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vaccine Development and Regulations: Legal and Ethical Considerations

I. P. Nwakoby, I. H. Iheukwumere, C. M. Iheukwumere, N. E. Nwakoby, M. A. Idigo, V. E. Ike

IPS Journal of Public Health · 2025

DOI: 10.54117/02eabv98 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IPS Journal of Public Health, 2025. Verfasst von I. P. Nwakoby und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Of the many public health interventions, vaccination stands as one of the most transformative, responsible for eradicating smallpox, curbing polio, and drastically reducing the global burden of infectious diseases. The journey from laboratory concept to licensed product, however, is a complex, costly, and highly regulated endeavor. This comprehensive review explores the multifaceted landscape of vaccine development through intersecting legal and ethical lenses. It delineates the standard multi-stage pathway for vaccine approval, from preclinical research through post-marketing surveillance, and examines the pivotal role of major regulatory agencies like the FDA and EMA in safeguarding efficacy and safety. The analysis is grounded in core ethical principles governing human subject research, including social value, informed consent, and a favorable risk-benefit ratio. Furthermore, the review investigates key legal structures, including vaccine injury compensation programs and the legal authority for mandates, while analyzing persistent tensions between intellectual property rights and equitable global access. Special ethical challenges, such as human infection studies and research in low-resource settings, are also addressed. The COVID-19 pandemic serves as a central case study, stress-testing these established frameworks. The unprecedented acceleration of development, reliance on Emergency Use Authorizations, and the stark emergence of vaccine nationalism highlighted both the remarkable agility of regulatory systems and profound vulnerabilities in global equity and public trust. The conclusion emphasizes that while the system successfully balanced urgency with prudence during the crisis, future preparedness requires strengthened regulatory harmony, robust manufacturing capacity, and more effective strategies to combat misinformation and uphold ethical commitments to global justice.

Zitieren

APA

Nwakoby, I. P., Iheukwumere, I. H., Iheukwumere, C. M., Nwakoby, N. E., Idigo, M. A., & Ike, V. E. (2025). Vaccine Development and Regulations: Legal and Ethical Considerations. IPS Journal of Public Health. https://doi.org/10.54117/02eabv98

Vancouver

Nwakoby IP, Iheukwumere IH, Iheukwumere CM, Nwakoby NE, Idigo MA, Ike VE. Vaccine Development and Regulations: Legal and Ethical Considerations. IPS Journal of Public Health. 2025. doi:10.54117/02eabv98

BibTeX
@article{Nwakoby2025,
  author = {Nwakoby, I. P. and Iheukwumere, I. H. and Iheukwumere, C. M. and Nwakoby, N. E. and Idigo, M. A. and Ike, V. E.},
  title = {Vaccine Development and Regulations: Legal and Ethical Considerations},
  journal = {IPS Journal of Public Health},
  year = {2025},
  doi = {10.54117/02eabv98}
}
Kostenlos starten →